ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effect of Meal Composition on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome

This study has been completed.

Sponsored by: National Institute of Child Health and Human Development (NICHD)
Information provided by: National Institute of Child Health and Human Development (NICHD)
ClinicalTrials.gov Identifier: NCT00455338
  Purpose

The primary objective is to determine if meals of different fat and fiber content affect postprandial plasma testosterone concentration in women with polycystic ovary syndrome. Our hypothesis is that a high-fiber meal will have a greater reduction in testosterone composition compared with a high-fat meal.


Condition Intervention
Polycystic Ovary Syndrome
Behavioral: Meal Composition

Drug Information available for:   Testosterone    Methyltestosterone    Oxymesterone    Testosterone enanthate    Testosterone Propionate    Testosterone undecanoate   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Uncontrolled, Crossover Assignment
Official Title:   The Effect of Meals of Varying Fat and Fiber Content on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome

Further study details as provided by National Institute of Child Health and Human Development (NICHD):

Primary Outcome Measures:
  • Testosterone

Secondary Outcome Measures:
  • SHBG
  • Glucose
  • Insulin

Estimated Enrollment:   16
Study Start Date:   May 2005
Study Completion Date:   November 2006

Detailed Description:

The study participants are 15 women with PCOS between the ages of 19-40. All participants must be in good health, non-smokers, and not pregnant or lactating. For three days prior to both study visits, participants follow a standard 2,000 calorie meal plan of approximately 30% fat, 55% carbohydrate and 15% protein. On the morning of the two study visits, participants arrive at the General Clinical Research Center at 0700 h. A venicatheter is inserted into an antecubital vein for collection of blood samples and the catheter is kept open with saline. A baseline blood sample is taken for measurement of estradiol, progesterone, glucose, insulin, testosterone, and sex hormone binding globulin (SHBG). Participants are then served the test meal and asked to consume it within 15 minutes. The high-fat, low-fiber and low-fat, high-fiber meals are isocaloric and are 62% and 6% fat, 24% and 81% carbohydrate, and have 1g and 26.8g of fiber, respectively. After each meal, a blood sample is taken at 30 minutes and every hour for six hours for measurement of testosterone, SHBG, glucose and insulin. During this time participants remain comfortably seated or reclined. After the last blood draw, the catheter was removed and participants are given a complementary meal.

  Eligibility
Ages Eligible for Study:   19 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Chronic oligo/anovulation – intermenstrual periods of ≥ 45 days or ≤ 8 menses per year.
  • Hyperandrogenemia - elevated total testosterone or free androgen index (ratio of testosterone/SHBG x 100). To participate in the study, women must have total testosterone >50 ng/dL or a free androgen index >1.5
  • In good general health

Exclusion Criteria:

  • Currently pregnant or lactating
  • Use of confounding medications such as oral contraceptives or other hormonal medication, lipid lowering medications or insulin sensitizing agents such as metformin or the glitazones.
  • Tobacco use
  • Alcohol consumption of more than two drinks per day
  • Unusual meal patterns (including no breakfast, breakfast before 6 am or breakfast after 10am.
  • Untreated hyperprolactinaemia (Prolactin >25ng/ml)
  • Uncontrolled hypothyroidism
  • History of blood clotting disorder
  • Diagnosis of anemia at baseline visit
  • Presence or history of diabetes mellitus
  • Existence of an organic intra cranial lesion such as a pituitary tumor.
  • Presence or history of coronary artery disease
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00455338

Sponsors and Collaborators

Investigators
Principal Investigator:     Richard S Legro, M.D.     Department of Obstetrics and Gynecology; Pennsylvania State University College of Medicine    
  More Information


Study ID Numbers:   K24-HD0147-6
First Received:   April 2, 2007
Last Updated:   April 2, 2007
ClinicalTrials.gov Identifier:   NCT00455338
Health Authority:   United States: Federal Government;   United States: Institutional Review Board

Keywords provided by National Institute of Child Health and Human Development (NICHD):
meal  
composition  
postprandial  
PCOS  
androgen  

Study placed in the following topic categories:
Genital Diseases, Female
Testosterone
Gonadal Disorders
Polycystic Ovary Syndrome
Endocrine System Diseases
Methyltestosterone
Endocrinopathy
Ovarian Diseases
Cysts
Ovarian Cysts
Testosterone 17 beta-cypionate

Additional relevant MeSH terms:
Neoplasms
Pathologic Processes
Disease
Syndrome
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones
Pharmacologic Actions
Androgens
Adnexal Diseases

ClinicalTrials.gov processed this record on October 22, 2008




Links to all studies - primarily for crawlers